Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liangjun Lu

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Science Bulletin|January 20, 2023
Nonvolatile waveguide transmission tuning with electrically-driven ultra-small GST phase-change materialHanyu Zhang, Linjie Zhou, Jian Xu, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|March 15, 2008
[Relationship between fibrinogen level and pathogenesis of sudden sensorineural hearing loss]Liangjun Lu, Zhisheng hong, Yinkun Yu, et al.
Nature Communications|June 19, 2026
Fully-connected microwave photonic multi-beamformer with fast beam-steering for broadband wireless communicationZiheng Ni, Liangjun Lu, Kai Fu, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2007
Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon systemYupeng He, Martin S King, Dale J Kempf, et al.
Nature Communications|April 29, 2024
Parallel wavelength-division-multiplexed signal transmission and dispersion compensation enabled by soliton microcombs and microringsYuanbin Liu, Hongyi Zhang, Jiacheng Liu, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
In vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavirSherie Masse, Xiaozhi Lu, Tatyana Dekhtyar, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2015
Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavirGretja Schnell, Rakesh Tripathi, Jill Beyer, et al.
Antiviral Research|September 29, 2004
Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazolesTim Middleton, Hock B Lim, Debra Montgomery, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitroLiangjun Lu, Tami J Pilot-Matias, Kent D Stewart, et al.
Plos One|October 5, 2018
Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvirGretja Schnell, Preethi Krishnan, Rakesh Tripathi, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Science Bulletin|January 20, 2023
Nonvolatile waveguide transmission tuning with electrically-driven ultra-small GST phase-change materialHanyu Zhang, Linjie Zhou, Jian Xu, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|March 15, 2008
[Relationship between fibrinogen level and pathogenesis of sudden sensorineural hearing loss]Liangjun Lu, Zhisheng hong, Yinkun Yu, et al.
Nature Communications|June 19, 2026
Fully-connected microwave photonic multi-beamformer with fast beam-steering for broadband wireless communicationZiheng Ni, Liangjun Lu, Kai Fu, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2007
Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon systemYupeng He, Martin S King, Dale J Kempf, et al.
Nature Communications|April 29, 2024
Parallel wavelength-division-multiplexed signal transmission and dispersion compensation enabled by soliton microcombs and microringsYuanbin Liu, Hongyi Zhang, Jiacheng Liu, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
In vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavirSherie Masse, Xiaozhi Lu, Tatyana Dekhtyar, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2015
Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavirGretja Schnell, Rakesh Tripathi, Jill Beyer, et al.
Antiviral Research|September 29, 2004
Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazolesTim Middleton, Hock B Lim, Debra Montgomery, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitroLiangjun Lu, Tami J Pilot-Matias, Kent D Stewart, et al.
Plos One|October 5, 2018
Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvirGretja Schnell, Preethi Krishnan, Rakesh Tripathi, et al.
Pageof 7